MBP and myeloid sarcoma: The same approach was tested in MS: following promising results in humanized mice (25), the MBP-derived peptide cocktail ATX-MS-1467 (Aptiope (https://apitope.com/multiple-sclerosis/) was tested for safety and efficacy in relapsing MS patients.